News Headlines Article

Federal prosecutors probing Glaxo diabetes drug Avandia
USA Today

British drug maker GlaxoSmithKline (GSK) reported Thursday that its controversial diabetes drug Avandia is under investigation by federal and state law enforcement officials in the U.S. The announcement came less than a month after the Food and Drug Administration issued severe restrictions on use of Avandia because of its links to heart attack. Regulators in Europe pulled the drug off the market altogether.